Press Releases
-
Dec 22, 2017- Required for financing agreement -
Biostage, Inc. (OTCQB: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
-
Dec 14, 2017- Investment will provide path forward for Biostage -
Biostage, Inc. (OTCQB: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
-
Oct 12, 2017- Emphasizes Robustness of its Technology Despite Financial Uncertainty -
Biostage, Inc. (OTC-QB: BSTG) ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
-
Oct 6, 2017- Delisted from NASDAQ effective October 6, 2017 -
Biostage, Inc. ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the esophagus, bronchus and...
-
Oct 2, 2017- Presentation with live video webcast Thursday, October 5th at 4:45PM PDT -
Biostage Inc., (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat congenital defects, cancers and other life-threatening...
